Strainsforpains, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Yeshua Simon Shainberg
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 244 Fifth Avenue New York City NY United States of America 10001
- IPO Date
- Jul 11, 2001
- CIK
- 0001666657
- Website
- strainsforpains.com
- Similar Companies
- Business
- Strainsforpains, Inc. (EBYH) operates as a medical marijuana data recommendation system and health and wellness company specializing in data technology for the global medical cannabis market; it develops and sells CBD/THC products including the proprietary Strainsforpains app, a user-based mobile and desktop application that scientifically matches cannabis brands, strains, cannabinoid levels, and consumption methods to patients' personal data, strain genetics, and specific ailments such as pain relief; and a CBD cream branded under Strainsforpains featuring licensed anti-inflammatory compounds. The company serves medical specialists, dispensaries, consumers, and health professionals through its recommendation engine, which aggregates a proprietary database of strains, cannabinoids, and medicinal applications validated by global research centers and semantic web technology. Founded in 1990 and headquartered at 244 Fifth Avenue, Suite 2387, New York, New York, Strainsforpains maintains operations in the United States with facilities including a 7-acre site in Pennsylvania, partnerships with hemp cultivators in Virginia and Pennsylvania, and distribution channels in the Greater New York City area. Recent developments include a strategic product commercialization agreement with Cannabis Science in August 2024 to expand cannabinoid-based offerings, including cancer drug development pipelines, educational programs, and fundraising for cancer awareness; large distribution orders such as $65,000 and $130,000 from NYC establishments and Exploration Solutions in late 2023 and early 2024; strategic alliances with GenBio, Inc. for CBD products and hemp suppliers to support supply chain reliability; and announcements in June 2025 of anticipated multiple acquisitions amid revenue growth and plans for NASDAQ uplisting, with 2024 sales guidance exceeding $500,000.
Strainsforpains EBYH (OTC: EBYH), Collaborates with Mt. Sinai Hospital in New York City and Johns Hopkins in Baltimore to Merge Advanced AI Data Integrations and Interactions Into Its Proprietary Healthcare APP for Instant Multiple Indications and Critical Ailments Professional Analytics
Strainsforpains (OTC: EBYH) Formally Announces Alliance with the 1-Million Strong Killing Cancers, Fight Club (1MSFC) and the Inaugural Live 1MSFC #1 MMA Fight for 4th Quarter 2024 in Florida! Appoints Former WWE, TV Executive VP, Mr.
Strainsforpains-EBYH, CEO Simon Shainberg Signs Strategic Product Commercialization Agreement with Cannabis Science; Shainberg's 2024 Guidance Projects Strong Revenue Growth For Its Multiplied Cannabinoid Drug Commercialization Pipeline
Strainsforpains, Inc. Investors Update: Strainsforpains, Inc. Showing Strong Revenue Growth
StrainsForPains, Inc. Discusses Inspiration, App Technology and CBD Market Entrance with The Stock Day Podcast
Strainsforpains Inc. Announces Corporate Update
Strainsforpains, Inc. secures its largest orders to date from NYC establishments